INTRODUCTION
STUDY GOALS AND OBJECTIVES
This immunoassay technology and application study provides a
detailed overview of current and prospective immunoassay technology and uses of
immunoassay technology in clinical, food safety, and environmental applications.
It supplements a 1992 Business Communication Company, Inc. survey of
immunoassays. In addition, the study addresses current and prospective changes
in these areas resulting from government regulations and patent legislation.
This report provides data analysis and forecasts through the year 2006 on:
- market composition and dynamics;
- market size;
- market participants with related market shares;
- current and emerging technologies;
- current and emerging applications;
- impact of and trends in legal government regulations.
REASONS FOR DOING THIS STUDY
As the human genome sequencing project nears completion and
other organisms' genomes are sequenced, the number of known proteins and
potential number of proteins is increasing. Many proteins are currently being
used and will be used as diagnostic tools in immunoassays. Enzyme-linked
immunosorbent, chemiluminescent, fluorescent, and radiolabelled are some of the
current immunoassay technologies being used. New immunoassay technologies are
also being developed. Since the number of known proteins and therefore the
potential number of immunoassays are increasing, it is interesting to analyze
the current and developing immunoassay technologies and markets.
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
The use and development of immunoassay technology in
clinical, food safety, and environmental applications is wide spread and will
continue to grow in all three of these areas.
The information in this report will be valuable to all
participants and observers of the immunoassay industry, and the related
equipment and reagents industries. The report should also be of interest to
researchers, laboratory, and government personnel working in other applications
of immunoassay that include home-use, veterinary diagnostics, plant disease, and
other biotechnology products testing.
The contents of this report are focused on the growth of
immunoassay technology in clinical, food safety, and environmental areas:
- technological apsects of immunoassay testing in the clinical, food safety,
and environmental areas;
- specific categories of immunoassay tests in the clinical, food safety, and
environmental areas;
- market segments;
- government regulations;
- technology patents and role they play in development;
- prospective technological developments of immunoassay tests in clinical,
food safety, and environmental areas; and
- new markets.
SCOPE AND FORMAT
This report is an analytical business tool whose primary
purpose is to show increased growth in the current and emerging clinical, food
safety, and environmental immunoassay fields. The report discusses specific,
patented technology, the role of government regulation and patents that affect
the development and growth of the various immunoassay markets.
Appendices include specialized and potential immunoassay
markets, relevant associations, URLs, conferences, and a list of companies
involved in clinical, food safety, and environmental immunoassay markets.
METHODOLOGY AND INFORMATION SOURCES
The primary data collection methodology for this report is
based on interviews with industry and government agency personnel, industry
observers, scientists and industry professional organizations. Additional
secondary data was collected using resources such as trade publications, trade
associations, company literature and online databases.
Growth forecasts are made in 2000 dollars based on the
manufacturers' (wholesale) price level unless otherwise noted.
BCC, Inc. personnel reviewed all collected data. Findings and
projections were confirmed with numerous industry sources.
View Cart
